The Duke Human Vaccine Institute (DHVI) is pleased to announce that Dr. Mike Datto joined the Institute as an affiliate faculty member on March 1st.
Mike Bradley Datto, MD, PhD is an AP/CP/MGP board-certified pathologist, Vice Chair of Clinical Pathology for the Department of Pathology at Duke University and the Medical Director and Associate Vice President for Duke University Health System Clinical Laboratories.
As Associate Vice President, Dr. Datto is responsible for maintaining the standards of the College of American Pathologists and CLIA/CMS within all clinical laboratories at Duke. Specifically, he oversees clinical testing; develops quality management systems and proficiency testing programs; provides consultation with ordering physicians; develops strategic plans in line with patient, physician and health system leadership needs; coordinates research and development; ensures adequate and appropriately trained personnel; and provides profession interpretation for molecular diagnostic testing including the wide range of PCR, quantitative PCR, sequencing, NGS and FISH based tests for inherited genetic diseases, hematologic malignancies, solid tumors and infectious diseases.
Dr. Datto also serves as the chair of the Accreditation Committee (AC) for the College of American Pathologists (CAP). The CAP is the largest accreditor of hospital based laboratories in the US and serves as a ‘deemed entity’ by the Center for Medicare Services. In this role, Dr. Datto oversees the committee that makes clinical accreditation decisions for approximately 7,000 clinical domestic and international laboratories.
Furthermore, Dr. Datto has an active academic program developing data system to aggregate, normalize and utilize high complexity and high volume laboratory data. Dr. Datto and his team have developed the Molecular Registry of Tumors - a software solutions that currently supports clinical trials matching, engagement with the AACR GENIE Project and the Molecular Tumor Board for Duke University Health System. The ultimate goal of this work is to ensure that the vast amount of laboratory data can be made useful and actually used to improve patient care.